中山那家医院看肠胃(中山肛肠检查的好医院) (今日更新中)

SAN DIEGO (KGTV) - As San Diego grapples with a homeless epidemic and rising rents, the city's housing supply remains a point of worry.According to the San Diego Housing Commission, the city twice the shortfall in housing than previously estimated. A 2017 report by the SDHC said the region could fall behind its goals by 50,000 units if housing supply followed the current production trend.By 2028, the organization estimated San Diego's housing needs would reach 150,000 to 200,000 units.RELATED: Under-utilized MTS land could be used for affordable housing, report saysThere is a silver lining, however. SDHC says San Diego has enough housing potential to meet its 10-year need if "all capacity sources are fully utilized," and could exceed that need by 30,000 units.Where are these potential sources of land? SDHC outlined them as follows: 876

SAN DIEGO (KGTV) - Crews are continuing to work Thursday to repair a ruptured gas line in the Mission Valley area that shut down a major San Diego freeway for hours and led to the evacuation of nearby homes and businesses the day before. 245

SAN DIEGO (KGTV) — As the world waits for a vaccine against the coronavirus, two San Diego biotechs are teaming up to develop a nasal spray using designer antibodies cloned from COVID-19 survivors.About 70 companies worldwide are working on therapies for COVID-19 using cloned antibodies, according to an estimate by the International AIDS Vaccine Initiative. A few of these treatments, known officially as monoclonal antibody therapies, have advanced to clinical trials.Most require an injection, but San Diego-based Diomics and its partner Active Motif, based in Carlsbad, are developing a once-a-day spray that could be easily self-administered.Early research suggests the coronavirus primarily enters the body through the nose. The spray, called Dioguard, is designed to coat the lining of the nasal cavity with cloned antibodies that are held in place for 24 hours or more using a proprietary polymer material developed by Diomics.Diomics CEO Anthony Zolezzi said he believes the spray “holds the key to allowing many aspects of life to resume until the day comes when there’s an effective vaccine in widespread use.”Diomics is also developing two tests for COVID-19 antibodies using its polymer beads, including a device that looks like a nicotine patch that is designed to monitor for infections for a week or more.RELATED: How a dot on your forearm could be the future sign of COVID immunityActive Motif is providing the cloned antibodies for the nasal spray. With a lab in Shanghai and other relationships in China, the Carlsbad company was able to clone antibodies from 11 Chinese survivors in February, before the World Health Organization declared a pandemic.When the company started the cloning project, they thought the virus would probably disappear in three to six months, said Active Motif CEO Ted DeFrank. “Then people started realizing, no this is going to be with us for a while.”The plasma from the 11 Chinese patients contained thousands of antibodies, and scientists with Active Motif set about selecting the one that was most effective, dubbed 414-1. The company says it can neutralize SARS-CoV-2 virus particles with 98 percent effectiveness.Monoclonal antibodies have some similarities to convalescent plasma, which is a complex cocktail of antibodies and other immune molecules drawn from the blood of recovered patients. One of the key differences is that cloned antibodies can be mass produced in a lab.Cloned antibodies have been used in treatments for more than 30 years, primarily for cancer. One such treatment famously helped former U.S. President Jimmy Carter beat melanoma.But of the more than 100 monoclonal antibody therapies licensed for use, only seven are for communicable diseases, according to IAVI.Historically, the treatments have been expensive and difficult to produce, but Diomics said it’s targeting a price of about a spray for Dioguard, roughly per bottle.“We do not want to have huge profits from a pandemic, that’s just wrong,” Zolezzi said. “We’re going to price this as effectively as we can for the masses. We want to get this out to the masses.”Animal testing is about to begin and the companies said they hope to progress to human trials soon. Their goal is to release the spray in early 2021, when a vaccine may be on the market but not yet widely available.If the spray works, it could be adapted to other viruses to help fight future pandemics, Zolezzi said."That’s our real goal," Zolezzi said. "That we never get caught flat-footed like this time." 3526

SAN DIEGO (KGTV) - Cinema Makeup School is at San Diego Comic-Con to turn some lucky attendees into zombies with special makeup effects.The Los Angeles-based theatrical makeup school is one of many special effects companies at the convention. 10News' Brooke Sargent volunteered for a complete transformation, becoming a dreaded creature in about 90 minutes as a crowd looked on.Cinema Makeup School has been teaching some of the industry's best artists since 1993. 472

SAN DIEGO (KGTV) — Chula Vista boasts several dog-friendly spots to take fido out for a play date or walk.Thankfully, the city sits in one of the most dog-friendly regions of the country, making choices for dog owners easy.Here are some parks in the South Bay that give pooches plenty of space to run, socialize, and play in the sun.Otay Ranch Town Center Dog Park (2015 Birch Rd.): Otay Ranch dog park features about 10,000-square-feet of open space for dogs to play. The park is close to dog-friendly retail and dining options in the town center too.Montevalle Park (840 Duncan Ranch Rd.): Dogs get plenty of space to play at Montevalle Park, including a separate area for small dogs, doggie water stations, and waste cleanup areas.Mount San Miguel Park (2335 Paseo Veracruz): Mount San Miguel Park features separate large and small dog areas and water for both dogs and humans.Orange Park (1475 Fourth Ave.): Provides a spot for doggos to run and roll around in dirt near the park's athletic fields. 1010

来源：资阳报